Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001213900-19-005045
Filing Date
2019-03-28
Accepted
2019-03-28 08:51:54
Documents
7
Period of Report
2019-03-28

Document Format Files

Seq Description Document Type Size
1 REPORT OF FOREIGN PRIVATE ISSUER f6k032819_therapixbio.htm 6-K 18790
2 FORM OF WARRANT BETWEEN THE COMPANY AND THE PURCHASERS IN THE OFFERINGS f6k032819ex4-1_therapix.htm EX-4.1 91568
3 ex5_1.htm EX-5.1 10615
4 FORM OF SECURITIES PURCHASE AGREEMENT BETWEEN THE COMPANY AND THE PURCHASERS IN f6k032819ex10-1_therapix.htm EX-10.1 221890
5 PRESS RELEASE DATED MARCH 28, 2019 f6k032819ex99-1_therapix.htm EX-99.1 12852
6 GRAPHIC img_001.jpg GRAPHIC 15951
7 GRAPHIC image_001.jpg GRAPHIC 11319
  Complete submission text file 0001213900-19-005045.txt   394610
Mailing Address 4 ARIEL SHARON STREET HASHAHAR TOWER, 16TH FLOOR GIV?ATAYIM L3 5320047
Business Address 4 ARIEL SHARON STREET HASHAHAR TOWER, 16TH FLOOR GIV?ATAYIM L3 5320047 972-3-6167055
Therapix Biosciences Ltd. (Filer) CIK: 0001611746 (see all company filings)

EIN.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-38041 | Film No.: 19710075
SIC: 2834 Pharmaceutical Preparations